UI

UC Investments

North America, California, United States, Oakland

Description

UC Investments focuses on long-term growth, sustainability, and fiduciary responsibility.

Investor Profile

UC Investments has backed more than 11 startups, with 4 new investments in the last 12 months alone. The firm has led 1 rounds, about 9% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series E rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Artificial Intelligence (AI).
  • Led 1 rounds in the past year.

Stage Focus

  • Series B (36%)
  • Series A (18%)
  • Series E (9%)
  • Series H (9%)
  • Series D (9%)
  • Series F (9%)
  • Seed (9%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Artificial Intelligence (Ai)
  • Life Science
  • Therapeutics
  • Machine Learning
  • Biopharma
  • Clinical Trials
  • Medical
  • Analytics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does UC Investments frequently co-invest with?

UCB Ventures
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
CA
North America, Massachusetts, United States, Boston
Co-Investments: 2
EC
North America, New York, United States, New York
Co-Investments: 3
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 4
BF
North America, California, United States, Berkeley
Co-Investments: 2
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 3
LYFE Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Schroders Capital
Europe, England, United Kingdom, London
Co-Investments: 3
Spur Capital Partners
North America, Oklahoma, United States, Bartlesville
Co-Investments: 2
The Column Group
North America, California, United States, San Francisco
Co-Investments: 5

Which angels does UC Investments often collaborate with?

Shared Deals: 1

What are some of recent deals done by UC Investments?

Prenosis

Chicago, Illinois, United States

Prenosis develops data-driven diagnostic tools and precision medicine solutions for acute care conditions.

Artificial Intelligence (AI)BiopharmaHealth CareHospitalMachine LearningMedicalPharmaceuticalPrecision Medicine
Series AJan 29, 2026
Amount Raised: $20,000,000
LMArena

San Francisco, California, United States

LMArena is a web-based platform that evaluates large language models (LLMs) through anonymous, crowd-sourced pairwise comparisons.

Artificial Intelligence (AI)Information ServicesMachine LearningProduct Research
Series AJan 6, 2026
Amount Raised: $150,000,000
LMArena

San Francisco, California, United States

LMArena focused on building a neutral, open, community-driven platform.

Artificial Intelligence (AI)CommunitiesMachine LearningProduct Research
SeedMay 21, 2025
Amount Raised: $100,000,000
Neurona Therapeutics

San Francisco, California, United States

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

BiotechnologyHealth CareTherapeutics
Series FApr 3, 2025
Amount Raised: $102,000,000
Eikon Therapeutics

Hayward, California, United States

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

BiotechnologyHealth CareLife ScienceMedical
Series DFeb 26, 2025
Amount Raised: $350,700,000
Horizon Surgical Systems

Malibu, California, United States

Horizon Surgical Systems develops AI-driven, imaging-guided surgical robotics for microsurgery.

Artificial Intelligence (AI)Health CareRobotics
Series AOct 16, 2024
Amount Raised: $30,000,000
Digestiva

Sacramento, California, United States

Digestiva develops the nutritional, sensory, and physiological properties of food and feed proteins with targeted biocatalysts.

Biotechnology
Series AJul 15, 2024
Amount Raised: $18,400,000
TORL BioTherapeutics

Culver City, California, United States

TORL BioTherapeutics is a clinical-stage biopharmaceutical business.

BiopharmaBiotechnologyClinical Trials
Series BApr 10, 2024
Amount Raised: $158,000,000
Neurona Therapeutics

San Francisco, California, United States

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

BiotechnologyHealth CareTherapeutics
Series EFeb 8, 2024
Amount Raised: $120,000,000
TORL BioTherapeutics

Culver City, California, United States

TORL BioTherapeutics is a clinical-stage biopharmaceutical business.

BiopharmaBiotechnologyClinical Trials
Series BApr 13, 2023
Amount Raised: $158,000,000

Find More Investors Like UC Investments

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

UC Investments | Pipeseed